Escient Pharmaceuticals
生物技术研究
San Diego，CA 3,025 位关注者
Targeted therapeutics for neurosensory-inflammatory disorders
关于我们
Escient is a clinical-stage pharmaceutical company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory diseases. Our pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for the treatment of various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Based in San Diego, California, Escient is led by an experienced team with specific expertise in GPCR drug discovery and development and funded by top-tier life science investors.
- 网站
-
https://www.escientpharma.com
Escient Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2018
地点
-
主要
获取路线
10578 Science Center Drive
Suite 250
US，CA，San Diego，92121
Escient Pharmaceuticals员工
-
Joshua Wollam
Associate Director, Translational Biology at Escient Pharmaceuticals
-
Christiane Villescaz
Associate Director, Translational Biology and Drug Discovery at Escient Pharmaceuticals
-
Rana Kilian
Executive Administration | Human Resources | Office Management | Organizational Efficiency & Maximum Productivity
-
Veena Viswanath
CTO at Architect Therapeutics